Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka

As there are limited data of the immunogenicity of the Sinopharm/BBIBP-CorV in different populations, antibody responses against different SARS-CoV-2 variants of concern and T cell responses, we investigated the immunogenicity of the vaccine, in individuals in Sri Lanka. SARS-CoV-2-specific antibodi...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Jeewandara, C, Aberathna, IS, Pushpakumara, PD, Kamaladasa, A, Guruge, D, Wijesinghe, A, Gunasekera, B, Tanussiya, S, Kuruppu, H, Ranasinghe, T, Dayarathne, S, Dissanayake, O, Gamalath, N, Ekanayake, D, Jayamali, J, Jayathilaka, D, Dissanayake, M, Madusanka, D, Jayadas, TT, Mudunkotuwa, A, Somathilake, G, Harvie, M, Nimasha, T, Danasekara, S, Wijayamuni, R, Schimanski, L, Rijal, P, Dong, T, Tan, TK, Townsend, A, Ogg, GS, Malavige, GN
التنسيق:	Journal article
اللغة:	English
منشور في:	Wiley 2022

Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka

مواد مشابهة